Literature DB >> 7259913

Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man.

N Edvardsson, S B Olsson.   

Abstract

The right ventricular repolarisation phase was studied electrophysiologically after an injection of 15 mg metoprolol in 16 healthy volunteers. Eight of them were restudied after chronic treatment with 400 mg metoprolol daily for five weeks. The assessment of the repolarisation time included ventricular effective refractory periods, monophasic action potential duration, and the QT interval measured during atrial stimulation at different driving frequencies. The acute administration of 15 mg metoprolol intravenously had no detectable effect on the repolarisation phase, while chronic treatment caused a significant increase of the ventricular effective refractory periods, monophasic action potential duration, and the QT interval during atrial stimulation. Thus the study confirmed the contrasting effect of acute and chronic beta-receptor blockade on the ventricular repolarisation time in man.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259913      PMCID: PMC482575          DOI: 10.1136/hrt.45.6.628

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  19 in total

Review 1.  A survey of the pharmacological properties of metoprolol in animals and man.

Authors:  B Ablad; K O Borg; E Carlsson; L EK; G Johnson; T Malmfors; C G Regårdh
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

Authors:  S B Olsson; L Brorson; E Varnauskas
Journal:  Br Heart J       Date:  1973-12

3.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

4.  The electrophysiology of propranolol in man.

Authors:  S F Seides; M E Josephson; W P Batsford; G M Weisfogel; S H Lau; A N Damato
Journal:  Am Heart J       Date:  1974-12       Impact factor: 4.749

5.  Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.

Authors:  C Wilhelmsson; J A Vedin; L Wilhelmsen; G Tibblin; L Werkö
Journal:  Lancet       Date:  1974-11-16       Impact factor: 79.321

6.  Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods.

Authors:  L Rydén; B Olsson; J Kvasnicka
Journal:  Cardiovasc Res       Date:  1975-01       Impact factor: 10.787

Review 7.  Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.

Authors:  B N Singh; D E Jewitt
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Beta blocking drugs as anti-arrhythmic agents.

Authors:  J D Fitzgerald
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-04

9.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

View more
  17 in total

Review 1.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

2.  Performance assessment of standard algorithms for dynamic R-T interval measurement: comparison between R-Tapex and R-T(end) approach.

Authors:  A Porta; G Baselli; F Lombardi; S Cerutti; R Antolini; M Del Greco; F Ravelli; G Nollo
Journal:  Med Biol Eng Comput       Date:  1998-01       Impact factor: 2.602

Review 3.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

4.  Effect of long term treatment with metoprolol and sotalol on ventricular repolarisation measured by use of transoesophageal atrial pacing.

Authors:  C Blomström-Lundqvist; M Dohnal; I Hirsch; A Lindblad; A Hjalmarson; S B Olsson; N Edvardsson
Journal:  Br Heart J       Date:  1986-02

5.  Lightning injury causing prolongation of the Q-T interval.

Authors:  A B Palmer
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

6.  The prolonged QT interval--a frequently unrecognized abnormality.

Authors:  R A Kenny; R Sutton
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

7.  QT and action potential duration.

Authors:  E M Vaughan Williams
Journal:  Br Heart J       Date:  1982-06

8.  Dynamics of ventricular repolarisation in the congenital long QT syndromes.

Authors:  N J Linker; A J Camm; D E Ward
Journal:  Br Heart J       Date:  1991-09

9.  Acute prolongation of myocardial refractoriness by sotalol.

Authors:  D H Bennett
Journal:  Br Heart J       Date:  1982-06

Review 10.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.